Literature DB >> 25572578

Cranial nerve palsies in childhood.

C J Lyons1, F Godoy1, E ALQahtani1.   

Abstract

We review ocular motor cranial nerve palsies in childhood and highlight many of the features that differentiate these from their occurrence in adulthood. The clinical characteristics of cranial nerve palsies in childhood are affected by the child's impressive ability to repair and regenerate after injury. Thus, aberrant regeneration is very common after congenital III palsy; Duane syndrome, the result of early repair after congenital VI palsy, is invariably associated with retraction of the globe in adduction related to the innervation of the lateral rectus by the III nerve causing co-contraction in adduction. Clinical features that may be of concern in adulthood may not be relevant in childhood; whereas the presence of mydriasis in III palsy suggests a compressive aetiology in adults, this is not the case in children. However, the frequency of associated CNS abnormalities in III palsy and the risk of tumour in VI palsy can be indications for early neuroimaging depending on presenting features elicited through a careful history and clinical examination. The latter should include the neighbouring cranial nerves. We discuss the impact of our evolving knowledge of congenital cranial dysinnervation syndromes on this field.

Entities:  

Mesh:

Year:  2015        PMID: 25572578      PMCID: PMC4330297          DOI: 10.1038/eye.2014.292

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  17 in total

1.  Pediatric third, fourth, and sixth nerve palsies: a population-based study.

Authors:  J M Holmes; S Mutyala; T L Maus; R Grill; D O Hodge; D T Gray
Journal:  Am J Ophthalmol       Date:  1999-04       Impact factor: 5.258

Review 2.  Oculomotor paresis with cyclic spasms. A critical review of the literature and a new case.

Authors:  I E Loewenfeld; H S Thompson
Journal:  Surv Ophthalmol       Date:  1975 Sep-Oct       Impact factor: 6.048

3.  Classification and treatment of superior oblique palsy.

Authors:  P Knapp
Journal:  Am Orthopt J       Date:  1974

4.  Ophthalmic complications of otitis media in children.

Authors:  Travis J Pollock; Peter Kim; Michael A Sargent; Maryam Aroichane; Christopher J Lyons; Jane A Gardiner
Journal:  J AAPOS       Date:  2011-06       Impact factor: 1.220

Review 5.  Sixth nerve palsies in children.

Authors:  M S Lee; S L Galetta; N J Volpe; G T Liu
Journal:  Pediatr Neurol       Date:  1999-01       Impact factor: 3.372

6.  The diagnosis and surgical management of acquired bilateral superior oblique palsy.

Authors:  N C Price; S Vickers; J P Lee; P Fells
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

7.  Primary aberrant aculomotor regeneration. A sign of intracavernous meningioma.

Authors:  N J Schatz; P J Savino; J J Corbett
Journal:  Arch Neurol       Date:  1977-01

Review 8.  Congenital cranial dysinnervation disorders: a concept in evolution.

Authors:  Thomas M Bosley; Khaled K Abu-Amero; Darren T Oystreck
Journal:  Curr Opin Ophthalmol       Date:  2013-09       Impact factor: 3.761

Review 9.  Adult-onset acquired oculomotor nerve paresis with cyclic spasms: relationship to ocular neuromyotonia.

Authors:  Neil R Miller; Andrew G Lee
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

10.  Congenital absence of the superior oblique tendon.

Authors:  E M Helveston; J G Giangiacomo; F D Ellis
Journal:  Trans Am Ophthalmol Soc       Date:  1981
View more
  2 in total

1.  Unilateral diplopia and ptosis in a child with COVID-19 revealing third cranial nerve palsy.

Authors:  Narcisse Elenga; Elise Martin; Max Gerard; Lindsay Osei; Najibullah Rasouly
Journal:  J Infect Public Health       Date:  2021-08-10       Impact factor: 7.537

2.  Diagnostic controversies in recurrent painful ophthalmoplegic neuropathy: single case report with a systematic review.

Authors:  Raffaele Falsaperla; Santiago Presti; Manuela Lo Bianco; Stefano Catanzaro; Silvia Marino; Martino Ruggieri
Journal:  Ital J Pediatr       Date:  2022-06-03       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.